BLACKBERRY is a Percutaneous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Allergy Laboratories, Inc.. The primary component is Blackberry.
| Product ID | 54575-353_dbe7bebd-e445-4e59-8302-e706b795fbde |
| NDC | 54575-353 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BLACKBERRY |
| Generic Name | Blackberry |
| Dosage Form | Injection, Solution |
| Route of Administration | PERCUTANEOUS; SUBCUTANEOUS |
| Marketing Start Date | 1972-08-29 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102192 |
| Labeler Name | Allergy Laboratories, Inc. |
| Substance Name | BLACKBERRY |
| Active Ingredient Strength | 1 g/20mL |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 1972-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| BLACKBERRY | 1 g/20mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-1298 | Blackberry | Blackberry |
| 36987-1299 | Blackberry | Blackberry |
| 36987-1300 | Blackberry | Blackberry |
| 36987-1301 | Blackberry | Blackberry |
| 49288-0054 | Blackberry | Blackberry |
| 54575-353 | BLACKBERRY | blackberry |